Exhaled breath condensate efficacy to identify mutations in patients with lung cancer: A pilot study.
KRAS
TP53
Exhaled breath condensate
lung cancer
mutational analysis
Journal
Nucleosides, nucleotides & nucleic acids
ISSN: 1532-2335
Titre abrégé: Nucleosides Nucleotides Nucleic Acids
Pays: United States
ID NLM: 100892832
Informations de publication
Date de publication:
2022
2022
Historique:
pubmed:
8
3
2022
medline:
28
6
2022
entrez:
7
3
2022
Statut:
ppublish
Résumé
Exhaled breath condensate (EBC) is used to investigate the efficacy of EBC to detect the genetic mutations in patients with lung cancer. Samples of 5 patients and 5 healthy volunteers were collected. DNA was extracted and used for amplification of hotspot regions of
Identifiants
pubmed: 35249462
doi: 10.1080/15257770.2022.2046278
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM